These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 29579760)

  • 41. An adolescent with bipolar disorder responding to a lower lithium concentration at maintenance treatment.
    Kul M; Gokler B; Kultur SE
    J Child Adolesc Psychopharmacol; 2009 Feb; 19(1):97-8. PubMed ID: 19232029
    [No Abstract]   [Full Text] [Related]  

  • 42. The impact of lithium prophylaxis on the course of bipolar disorder: a review of the research evidence.
    Maj M
    Bipolar Disord; 2000 Jun; 2(2):93-101. PubMed ID: 11252656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacotherapy and risk of suicidal behaviors among patients with bipolar disorder.
    Bowden C; Fawcett J
    JAMA; 2004 Feb; 291(8):939; author reply 940. PubMed ID: 14982904
    [No Abstract]   [Full Text] [Related]  

  • 44. [Recurrence following discontinuation of 28 years of lithium therapy].
    Wegmann SD; Kessing LV
    Ugeskr Laeger; 2011 Mar; 173(11):820-1. PubMed ID: 21402017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacogenetic aspects of bipolar disorder.
    Alda M
    Pharmacogenomics; 2003 Jan; 4(1):35-40. PubMed ID: 12517284
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Investigating responders to lithium prophylaxis as a strategy for mapping susceptibility genes for bipolar disorder.
    Alda M; Grof P; Rouleau GA; Turecki G; Young LT
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1038-45. PubMed ID: 15946781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lithium Treatment in Children and Adolescents.
    Duffy A; Grof P
    Pharmacopsychiatry; 2018 Sep; 51(5):189-193. PubMed ID: 29490377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacotherapy and risk of suicidal behaviors among patients with bipolar disorder.
    Yerevanian BI; Koek RJ; Feusner JD
    JAMA; 2004 Feb; 291(8):939; author reply 940. PubMed ID: 14982905
    [No Abstract]   [Full Text] [Related]  

  • 49. New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview.
    Bortolozzi A; Fico G; Berk M; Solmi M; Fornaro M; Quevedo J; Zarate CA; Kessing LV; Vieta E; Carvalho AF
    Pharmacol Rev; 2024 May; 76(3):323-357. PubMed ID: 38697859
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased Beta Frequency (15-30 Hz) Oscillatory Responses in Euthymic Bipolar Patients Under Lithium Monotherapy.
    Tan D; Özerdem A; Güntekin B; Atagün MI; Tülay E; Karadağ F; Başar E
    Clin EEG Neurosci; 2016 Apr; 47(2):87-95. PubMed ID: 25465436
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validating MARK2 Gene Polymorphism as a Predictor of Response to Lithium Treatment in Bipolar Patients.
    Aghabozorg Afjeh SS; Shams J; Hamednia S; Boshehri B; Amini A; Omrani A; Omrani MD
    Iran Biomed J; 2022 Mar; 26(2):110-5. PubMed ID: 34953473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of lithium on bipolar disorder.
    Malhi GS
    Bipolar Disord; 2009 Jun; 11 Suppl 2():1-3. PubMed ID: 19538680
    [No Abstract]   [Full Text] [Related]  

  • 53. Lithium for older adults with bipolar disorder: Should it still be considered a first-line agent?
    Shulman KI
    Drugs Aging; 2010 Aug; 27(8):607-15. PubMed ID: 20658789
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Review: lithium reduces the risk of suicide compared with placebo in people with depression and bipolar disorder.
    Young AH
    Evid Based Ment Health; 2013 Nov; 16(4):112. PubMed ID: 24046391
    [No Abstract]   [Full Text] [Related]  

  • 55. Predicting response to lithium in bipolar disorder: a critical review of pharmacogenetic studies.
    Smith DJ; Evans R; Craddock N
    J Ment Health; 2010 Apr; 19(2):142-56. PubMed ID: 20433322
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Lithium: 55 years of history in the therapy of bipolar affective disorder].
    Mármol F
    Med Clin (Barc); 2006 Jul; 127(5):189-95. PubMed ID: 16834956
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The pharmacological treatment of bipolar disorder: the question of modern advances.
    Hirschowitz J; Kolevzon A; Garakani A
    Harv Rev Psychiatry; 2010; 18(5):266-78. PubMed ID: 20825264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Are lithium effects dependent on genetic/epigenetic architecture?
    Walss-Bass C; Fries GR
    Neuropsychopharmacology; 2019 Jan; 44(1):228. PubMed ID: 30194423
    [No Abstract]   [Full Text] [Related]  

  • 59. Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients.
    Tondo L; Baldessarini RJ
    Epidemiol Psichiatr Soc; 2009; 18(3):179-83. PubMed ID: 20034193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients.
    Squassina A; Pisanu C; Congiu D; Caria P; Frau D; Niola P; Melis C; Baggiani G; Lopez JP; Cruceanu C; Turecki G; Severino G; Bocchetta A; Vanni R; Chillotti C; Del Zompo M
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1241-7. PubMed ID: 27084304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.